XGMA(SH:600815)2024-10-29 09:51Financial Performance - Operating revenue for Q3 2024 was CNY 162,542,842.97, a decrease of 42.64% compared to the same period last year[2] - Net profit attributable to shareholders for Q3 2024 was CNY 1,524,737.38, while the net profit attributable to shareholders after deducting non-recurring gains and losses was CNY -14,751,429.50[2] - Total operating revenue for the first three quarters of 2024 was CNY 562,262,727.04, a decrease of 11.36% compared to CNY 634,424,871.16 in the same period of 2023[12] - Operating profit for the first three quarters of 2024 was CNY 56,968,732.17, a significant recovery from a loss of CNY 19,898,546.63 in the same period of 2023[12] - Net profit for the first three quarters of 2024 reached CNY 45,800,299.28, compared to a net loss of CNY 19,434,529.04 in the same period of 2023[12] - The net profit for Q3 2024 was CNY 45,800,299.28, a significant improvement compared to a net loss of CNY 31,353,166.22 in Q3 2023[13] - The net profit attributable to shareholders of the parent company was CNY 7,511,351.35, recovering from a loss of CNY 44,040,873.42 in the same period last year[13] - The total comprehensive income for Q3 2024 reached CNY 48,805,147.79, compared to a loss of CNY 31,813,692.05 in Q3 2023[13] Cash Flow - Net cash flow from operating activities for Q3 2024 increased by 104.39% to CNY 59,050,482.83[2] - Cash flow from operating activities generated a net inflow of CNY 136,227,207.10, a substantial increase from CNY 27,999,938.56 in the previous year[14] - Cash inflow from operating activities was CNY 259,201,412.97, down 23.16% from CNY 337,519,606.35 in the same period of 2023[21] - The net cash flow from operating activities was -28,287,559.35 CNY, compared to -22,797,799.22 CNY in the previous year, indicating a decline in operational cash generation[22] - The cash outflow from operating activities totaled 287,488,972.32 CNY, compared to 360,317,405.57 CNY in the previous year, showing an improvement in operational cash management[22] Assets and Liabilities - Total assets at the end of Q3 2024 were CNY 2,378,527,305.15, a decrease of 0.50% from the end of the previous year[3] - Total current assets amounted to CNY 1,771,270,652.98, showing a slight increase from CNY 1,763,491,757.85 at the end of 2023[9] - The total assets as of September 30, 2024, were CNY 2,378,527,305.15, down from CNY 2,390,416,201.75 at the end of 2023, reflecting a decrease of approximately 0.5%[10] - The total liabilities included accounts payable of CNY 181,230,155.37, which increased from CNY 151,091,912.14, marking an increase of about 19.9%[10] - The company reported a decrease in total liabilities to CNY 631,256,970.74, down from CNY 693,718,778.10 year-on-year[11] - The total liabilities decreased to CNY 347,474,205.14 from CNY 388,389,493.35, a reduction of 10.55%[18] Inventory and Current Assets - The company's inventory decreased to CNY 235,801,546.61 from CNY 353,102,647.47, indicating a reduction of about 33.3%[10] - The company's inventory decreased to CNY 26,674,363.53 from CNY 46,179,974.55 year-over-year[16] - The accounts receivable slightly decreased to CNY 292,611,219.80 from CNY 295,253,291.37, a change of about 0.9%[9] Cost Management and Profitability - The company implemented cost control measures, which improved operating profit margins and contributed to turning profits around[4] - The decrease in operating revenue was primarily due to a reduction in sales volume of the subsidiary Xiamen XGMA Zhongtie Shield Machine[7] - The company achieved a significant increase in cash flow from operations by enhancing inventory turnover and reducing capital occupation[7] - The company plans to continue optimizing product structure and enhancing operational efficiency to improve profitability in the future[4] - The company plans to focus on market expansion and new product development in the upcoming quarters[12] Research and Development - Research and development expenses increased to CNY 21,085,243.32, up 21.5% from CNY 17,327,668.47 in the previous year[12] - Research and development expenses for the first three quarters of 2024 were CNY 13,083,330.42, slightly down from CNY 13,666,348.87 in 2023[19] Investment Income - The company reported a significant increase in investment income to CNY 26,663,196.49, compared to CNY 17,280,958.75 in the same period of 2023[12] - The company reported an investment income of CNY 25,516,585.39, an increase from CNY 16,682,537.03 in the previous year[19] Changes in Shareholders and Events - The company has not reported any changes in major shareholders or significant events affecting the operational status during the reporting period[9] - The company has adopted new accounting standards starting from 2024, which may impact future financial reporting[22]